Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibit...
Q1 2026
May 12, 2026
FY 2025
Mar 19, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 5, 2025